Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics total assets
Total assets on the balance sheet at the end of each period.
Calidi Biotherapeutics's total assets was $7.20M at Jun 30, 2026. For fiscal 2025 it was $8.86M, down 37.5% from the year before. The highest annual figure on record is $231.77M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.86M | -37.5% |
| FY2024 | Dec 31, 2024 | $14.18M | +41.6% |
| FY2023 | Dec 31, 2023 | $10.02M | +285.8% |
| FY2022 | Dec 31, 2022 | $2.60M | -98.9% |
| FY2021 | Dec 31, 2021 | $231.77M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.20M | -23.0% |
| Q1 FY2026 | Mar 31, 2026 | $9.59M | -36.3% |
| Q4 FY2025 | Dec 31, 2025 | $8.86M | -37.5% |
| Q3 FY2025 | Sep 30, 2025 | $14.03M | +110.7% |
| Q2 FY2025 | Jun 30, 2025 | $9.35M | +45.4% |
| Q1 FY2025 | Mar 31, 2025 | $15.06M | +103.4% |
| Q4 FY2024 | Dec 31, 2024 | $14.18M | +41.6% |
| Q3 FY2024 | Sep 30, 2024 | $6.66M | -64.2% |
| Q2 FY2024 | Jun 30, 2024 | $6.43M | -85.4% |
| Q1 FY2024 | Mar 31, 2024 | $7.41M | -82.8% |
| Q4 FY2023 | Dec 31, 2023 | $10.02M | +285.8% |
| Q3 FY2023 | Sep 30, 2023 | $18.59M | -55.9% |
| Q2 FY2023 | Jun 30, 2023 | $44.01M | -80.9% |
| Q1 FY2023 | Mar 31, 2023 | $43.18M | -81.3% |
| Q4 FY2022 | Dec 31, 2022 | $2.60M | -98.9% |
| Q3 FY2022 | Sep 30, 2022 | $42.16M | -81.8% |
| Q2 FY2022 | Jun 30, 2022 | $231.02M | – |
| Q1 FY2022 | Mar 31, 2022 | $231.24M | – |
| Q4 FY2021 | Dec 31, 2021 | $231.77M | – |
| Q3 FY2021 | Sep 30, 2021 | $232.01M | – |
See a number that looks wrong?